Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil combined with neuromuscular blockers in pediatric endotracheal intubation
ChiCTR2400089691Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: No major complications and successful first intubation. Started Sep 2024; status: recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2400089691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089691.